|
Food and
Drug Administration(FDA) is encouraging pharmaceutical and biotech
companies to submit regulatory information in electronic medium.
This action reduces usage of large volumes of paper and help
companies to exploit the advantages of using information technology
in terms of portability, storage and retrieval. The electronic
submissions have the same stringent regulations as in the case of
paper submissions. Enrollment Limited.
Topics
:
Testing(QA in IT):
- Environment and scope
- SDLC and importance of QA
- Different models of SDLC
- Manual testing
- Automated testing
- Tools for testing
- Testing methodologies
Industry Specific:
- FDA guidelines
- FDA Regulations
- GxP Environment
- 21 CFR Part 11 Requirements
- Document Management
- Auditing and Conclusions
IES, Inc., 2900
Gordon Avenue, Suite 100, Santa Clara, CA 95051 PH:
408-738-1342 X 01 Email: ra@iesols.com |